These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27525937)

  • 1. Increased risk of breast cancer in individuals carrying the TNRC9 rs3803662 C>T polymorphism: a meta-analysis of case-control studies.
    Wang Q; Wang NY; Cao XM; Sun X; Shen D; Yuan M; Chen JF
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects.
    Chen MB; Wu XY; Shen W; Wei MX; Li C; Cai B; Tao GQ; Lu PH
    Breast Cancer Res Treat; 2011 Feb; 126(1):177-83. PubMed ID: 20703937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
    Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
    J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.
    Tajbakhsh A; Javan FA; Rivandi M; Moezzi A; Abedini S; Asghari M; Farjami Z; Soltanian H; Shandiz FH; Kooshyar MM; Pasdar A
    Mol Biol Rep; 2019 Feb; 46(1):805-811. PubMed ID: 30515698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
    Liang J; Chen P; Hu Z; Shen H; Wang F; Chen L; Li M; Tang J; Wang H; Shen H
    Breast Cancer Res Treat; 2010 Nov; 124(1):237-41. PubMed ID: 20213080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
    Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
    Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
    Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L
    Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
    Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
    Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
    Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls.
    Zhang L; Long X
    Sci Rep; 2015 Aug; 5():12773. PubMed ID: 26239137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Association of
    Solis-Coronado O; Villarreal-Vela MP; Rodríguez-Gutiérrez HF; González-Guerrero JF; Cerda-Flores RM; Alcorta-Núñez F; Camarillo-Cárdenas KP; Pérez-Ibave DC; Vidal-Gutiérrez O; Ramírez-Correa GA; Garza-Rodríguez ML
    Curr Oncol; 2022 Feb; 29(2):1008-1017. PubMed ID: 35200585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
    Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
    PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of single nucleotide polymorphism rs3803662 with the risk of breast cancer.
    Yang Y; Wang W; Liu G; Yu Y; Liao M
    Sci Rep; 2016 Jun; 6():29008. PubMed ID: 27350156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis.
    Peng L; Li P; Chen J; Yan K; Huo F; Han L; Li C; Tan S; Jiang X
    PLoS One; 2013; 8(7):e67738. PubMed ID: 23861796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNRC9/LOC643714 polymorphisms are not associated with breast cancer risk in Chinese women.
    Li L; Zhou X; Huang Z; Liu Z; Song M; Guo Z
    Eur J Cancer Prev; 2009 Aug; 18(4):285-90. PubMed ID: 19398914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
    Gao F; Ge R
    Clin Breast Cancer; 2019 Oct; 19(5):e596-e610. PubMed ID: 31324582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the TOX3 rs3803662 C>T polymorphism and recurrent miscarriage in a southern Chinese population.
    Huang W; Zhou H; Li Q; Pi L; Xu Y; Fu L; Yang Y; Lu Z; Che D; Gu X
    J Clin Lab Anal; 2019 Nov; 33(9):e22992. PubMed ID: 31454102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
    Chen Y; Shi C; Guo Q
    World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.